RHBC
ELAN icon

R.H. Bluestein & Co’s Elanco Animal Health ELAN Stock Holding History

R.H. Bluestein & Co’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,000
Closed -$203K – 339
2019
Q2 		$203K Buy
+6,000
New +$195K 0.01% 302

Other funds holding ELAN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

R.H. Bluestein & Co's ELAN Position: Q3 2019 in Review

R.H. Bluestein & Co sold out of Elanco Animal Health (ELAN) in Q3 2019, closing a stake of 6,000 shares — an estimated $203K sold.

R.H. Bluestein & Co first reported a position in ELAN in Q2 2019 and held it in 1 quarter. The position peaked at $203K in Q2 2019. 376 funds tracked by Wall St. Rank hold ELAN as of Q3 2019.

  • R.H. Bluestein & Co reported no remaining Elanco Animal Health position as of Q3 2019 after selling out during the quarter.
  • R.H. Bluestein & Co sold 6,000 Elanco Animal Health shares in Q3 2019, an estimated $203K.
  • R.H. Bluestein & Co first reported a position in Elanco Animal Health in Q2 2019 and held it in 1 quarter.
  • R.H. Bluestein & Co's Elanco Animal Health position peaked at $203K in Q2 2019.
  • 376 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2019.

Based on R.H. Bluestein & Co's 13F filing for Q3 2019, filed 13 Nov 2019.